|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date07 Apr 2021 |
对照果纳芬比较重组人促卵泡激素注射液在体外受精-胚胎移植中行控制性超促排卵的疗效和安全性的Ⅲ期临床研究
[Translation] Phase III clinical study comparing the efficacy and safety of recombinant human follicle-stimulating hormone injection with GONAL-F in controlled ovarian hyperstimulation during in vitro fertilization-embryo transfer
通过与Gonal-F Pen比较,评价重组人促卵泡激素注射液在体外受精-胚胎移植中行控制性超促排卵的疗效和安全性
[Translation] To evaluate the efficacy and safety of recombinant human follicle-stimulating hormone injection in controlled ovarian hyperstimulation during in vitro fertilization-embryo transfer by comparing with Gonal-F Pen
100 Clinical Results associated with Icon Clinical Research (Beijing) Co., Ltd.
0 Patents (Medical) associated with Icon Clinical Research (Beijing) Co., Ltd.
100 Deals associated with Icon Clinical Research (Beijing) Co., Ltd.
100 Translational Medicine associated with Icon Clinical Research (Beijing) Co., Ltd.